4
Changes in Ownership
CG Oncology, Inc. Filed Acc 0000950170-25-060145
Director sold 1,000 shares at $30.76 ($30,760)
- Director acquired 1,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
POST LEONARD E · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-04-28 | Exercise or conversion : show line 1 in the form 10b5-1 | +1,000 | $0.60 | $600 | 1,000 | D |
| 2025-04-28 | Sale : show line 2 in the form 10b5-1 | −1,000 | $30.76 | $30,760 | 0 | D |
| Open-market sales · 1,000 sh · avg $30.76 · $30,760 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-04-28 | Exercise or conversion : show line 3 in the form 10b5-1 Director Stock Option (right to buy) | −1,000 | 129,077 | D |
Loading xslF345X05/ownership.xml…